Micatu, Inc. provider of next generation optical based sensors, measurement and biomedical instruments, has announced the relocation of its business operations to the Ceramics Corridor Innovation Center (CCIC). The new facility, located at 109 Canada Road, Painted Post, New York, 14870, will accommodate the companyʼs staff expansion to meet the companyʼs recent growth within the Oncology medical instrumentation markets.
“This presents a great opportunity to leverage the technical synergies between Micatu and the Ceramics Corridor Innovation Center (CCIC) in a cost effective manner,” stated Michael Oshetski, CEO of Micatu, Inc. “As Micatu grows, we have the access to flexible facilities for both corporate offices and specialized laboratory space. This gives us a differential advantage to meeting our customersʼ needs by focusing on the bottom line, and freeing up operational capital for new opportunities.”
“Our internal management team is comprised of a blended mix of senior technical, visionary and commercialization practice management to ensure that our advances in technology are matched with real world demand and that our research results in a commercialized product or service offering”, stated Mike Jagielski, Micatuʼs Chief Operating Officer.
“Recently, Micatu was awarded an exclusive license from a prestigious US Government Federal Agency for the design, production and commercialization of a bio-medical instrument that has the capability of reducing existing technology costs for similar instruments by a factor of 25X to 50X. Micatu was distinguished as the clear winner in a field of almost 50 entrants by demonstrating our commercialization ability first and foremost, followed by our advanced technical expertise.”
Micatuʼs new facility is centrally located in Upstate New York, next to the I-86 corridor and the Elmira regional airport (ELM).
Source: Micatu
